TOPAMAX- topiramate tablet, coated
TOPAMAX- topiramate capsule, coated pellets Stany Zjednoczone - angielski - NLM (National Library of Medicine)

topamax- topiramate tablet, coated topamax- topiramate capsule, coated pellets

janssen pharmaceuticals, inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 25 mg - topamax ® is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. topamax ® is indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with lennox-gastaut syndrome in patients 2 years of age and older. topamax ® is indicated for the preventive treatment of migraine in patients 12 years of age and older. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to topamax ® during pregnancy. patients should be encouraged to enroll in the north american antiepileptic drug (naaed) pregnancy registry if they become pregnant. this registry is collecting information about the safety of antiepileptic drugs during pregnancy. to enroll, patients can call the toll-free number 1-888-233-2334. information about th

PONVORY- ponesimod tablet, film coated
PONVORY- ponesimod kit Stany Zjednoczone - angielski - NLM (National Library of Medicine)

ponvory- ponesimod tablet, film coated ponvory- ponesimod kit

janssen pharmaceuticals, inc - ponesimod (unii: 5g7akv2mkp) (ponesimod - unii:5g7akv2mkp) - ponvory is indicated for the treatment of relapsing forms of multiple sclerosis (ms), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ponvory is contraindicated in patients who: - in the last 6 months, have experienced myocardial infarction, unstable angina, stroke, transient ischemic attack (tia), decompensated heart failure requiring hospitalization, or class iii or iv heart failure [see warnings and precautions (5.2)] - have presence of mobitz type ii second-degree, third-degree atrioventricular (av) block, sick sinus syndrome, or sino-atrial block, unless patient has a functioning pacemaker [see warnings and precautions (5.2)] risk summary there are no adequate and well-controlled studies of ponvory in pregnant women. in animal studies, administration of ponesimod during pregnancy produced adverse effects on development, including embryo lethality and fetal malformations, in the absence of maternal toxic

Concerta XL 36 mg prolonged-release tablets Wielka Brytania - angielski - myHealthbox

concerta xl 36 mg prolonged-release tablets

janssen-cilag ltd - methylphenidate hydrochloride - prolonged-release tablet - 36 mg - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit hyperactivity disorder (adhd) in children aged 6 years of age and over when remedial measures alone prove insufficient

Concerta XL 18 mg prolonged-release tablets Wielka Brytania - angielski - myHealthbox

concerta xl 18 mg prolonged-release tablets

janssen-cilag ltd - methylphenidate hydrochloride - prolonged-release tablet - 18 mg - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit hyperactivity disorder (adhd) in children aged 6 years of age and over when remedial measures alone prove insufficient.

Concerta XL 54mg prolonged release tablets Wielka Brytania - angielski - myHealthbox

concerta xl 54mg prolonged release tablets

janssen-cilag ltd - methylphenidate hydrochloride - prolonged-release tablet - 54 mg - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit hyperactivity disorder in children aged 6 years of age and over when remedial measures alone prove insufficient.

Cilest 35/ 250 micrograms film-coated tablets Wielka Brytania - angielski - myHealthbox

cilest 35/ 250 micrograms film-coated tablets

janssen-cilag ltd - norgestimate, ethinylestradiol - film-coated tablet - 35/ 250 micrograms - hormonal contraceptives for systemic use; progestogens and estrogens, fixed combinations - contraception and the recognised indications for such estrogen/progestogen combinations

Durogesic DTrans 12 mcg/hr Transdermal Patch Wielka Brytania - angielski - myHealthbox

durogesic dtrans 12 mcg/hr transdermal patch

janssen-cilag ltd - fentanyl - transdermal patch - 2.1 mg - phenylpiperidine derivatives - in adults: is indicated in the management of chronic intractable pain due to cancer; in the management of chronic intractable pain in children:is indicated in long term management of severe chronic pain in children receiving opioid therapy from 2 years of age.

Durogesic DTrans 100 mcg/hr Transdermal Patch Wielka Brytania - angielski - myHealthbox

durogesic dtrans 100 mcg/hr transdermal patch

janssen-cilag ltd - fentanyl - transdermal patch - 16.8 mg. - opioid analgesic, phenylpiperidone derivative - in adults it is indicated in the management of chronic intractable pain due to cancer and in the management of chronic intractable pain in children it is indicated for long term management of severe chronic pain in children receiving opioid therapy from 2 years of age

DAKTARIN CREAM Izrael - angielski - Ministry of Health

daktarin cream

j-c health care ltd - miconazole nitrate - cream - miconazole nitrate 20 mg/g - miconazole - miconazole - broad spectrum antimycotic